Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, T-Cell, Peripheral

Explore clinical trials studying Lymphoma, T-Cell, Peripheral. Study availability and eligibility vary by location and protocol.

235 public trials 60 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, T-Cell, Peripheral trial results

Completed

BR101801 in Adult Patients With Advanced Hematologic Malignancies(Phase I)

NCT04018248

Conditions
B Cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +36 more
Locations
  • Henry Ford Hospital Detroit, Michigan, United States
  • National Cancer Center Goyang-si, Gyeonggi-do, South Korea
  • Seoul National University Bundang Hospital Seongnam-si, Gyeonggi-do, South Korea
  • Chonnam National University Hwasun Hospital Hwasun, Jeollanam-do, South Korea
View Trial Details
Completed

AZD4205 in Peripheral T Cell Lymphoma Following First-Line Therapy (JACKPOT26)

NCT06511869

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Anhui Provincial Hospital (The First Affiliated Hospital of USTC) Hefei, Anhui, China
  • Peking university Third Hospital Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
  • Guangdong Provincial People's Hospital Guangzhou, Guangdong, China
View all 23 locations
View Trial Details
Completed

Assessing An Oral Janus Kinase Inhibitor, AZD4205 as Monotherapy in Patients Who Have PTCL (JACKPOT8)

NCT04105010

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • Yale Cancer Center New Haven, Connecticut, United States
  • Winship Cancer Institute Atlanta, Georgia, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
View all 50 locations
View Trial Details
Completed

Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors

NCT05225584

Conditions
Cutaneous T-cell Lymphoma (CTCL), Hematologic Diseases, Hemic and Lymphatic Diseases, +22 more
Locations
  • UC Irvine Health-Chao Family Comprehensive Cancer Center Orange, California, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
  • Henry Ford Hospital Detroit, Michigan, United States
  • Hackensack University Medical Center, John Theurer Cancer Center Hackensack, New Jersey, United States
View all 13 locations
View Trial Details
Completed

A Study of Duvelisib in Participants With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

NCT03372057

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California - Irvine Irvine, California, United States
  • University of California - Los Angeles Los Angeles, California, United States
  • Emory University Winship Cancer Institute Atlanta, Georgia, United States
View all 36 locations
View Trial Details

Related conditions